Kyle Gano
Patrimonio netto: 25 M $ in data 30/06/2026
Patrimonio netto: 25 M $ in data 30/06/2026
Kyle W.
Gano is currently President, Chief Executive Officer & Director at Neurocrine Biosciences, Inc. since 2024.
Dr. Gano is also a Director at Pharmaceutical Research & Manufacturers of America since 2024.
Education history includes an undergraduate degree from the University of Washington in 1996, an MBA and a doctorate from the University of California, Los Angeles, and an undergraduate degree from the University of Oregon.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 150.991 ( 0,15% ) | 25 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Amministratore Delegato | 11/10/2024 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | 01/10/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale